These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9031590)

  • 61. Humoral immune response in Yersinia enterocolitica O:5 induced arthritis in hamsters.
    Di Genaro MS; Escudero ME; Velázquez LC; Muñoz E; Aguilera C; Juárez A; Scardapane L; Stefanini de Guzmán AM
    Microbiol Immunol; 1997; 41(8):615-20. PubMed ID: 9310941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to enterobacterial common antigen (ECA)].
    Rastawicki W
    Med Dosw Mikrobiol; 2007; 59(2):93-102. PubMed ID: 17929407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experimental intestinal infection of rats by Yersinia enterocolitica 0:3. A follow-up study with specific antibodies to the virulence plasmid specified antigens.
    Skurnik M; Poikonen K
    Scand J Infect Dis; 1986; 18(4):355-64. PubMed ID: 3532305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antigenicity of protein and lipopolysaccharide from Yersinia enterocolitica.
    Ogata S; Kanamori M; Miyashita K
    Contrib Microbiol Immunol; 1979; 5():64-72. PubMed ID: 119613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibodies against cell envelope antigens of Yersinia enterocolitica in reactive arthritis and ankylosing spondylitis.
    van Bohemen CG; van Alphen AJ; Zanen-Lim OG; Dekker-Saeys AJ; Zanen HC
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):83-4. PubMed ID: 6652395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunological characterization of Yersinia enterocolitica O:9 and O:3 LPS antigens by monoclonal antibodies.
    Weninger J; Wartenberg K; Röllinghoff M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):298-313. PubMed ID: 3218391
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis in Yersinia enterocolitica infection.
    Stolk-Engelaar V; Hoogkamp-Korstanje J
    Contrib Microbiol Immunol; 1995; 13():137-9. PubMed ID: 8833817
    [No Abstract]   [Full Text] [Related]  

  • 70. Local expression of cytokine mRNA in spleen and Peyer's patches of rats is involved in resistance against infection with Yersinia enterocolitica.
    Odinot PT; Curfs JH; Meis JF; Melchers WJ; Hoogkamp-Korstanje JA
    Cytokine; 1998 Mar; 10(3):206-12. PubMed ID: 9576066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of Yersinia enterocolitica O:3 derivatives on B lymphocyte activation in vivo.
    Crespo Ade M; Falcão DP; Ferreira de Araújo PM; Machado de Medeiros BM
    Microbiol Immunol; 2002; 46(2):95-100. PubMed ID: 11939584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Occurrence and level of antibodies against Yersinia enterocolitica O antigens detected in select human groups by the passive hemagglutination test].
    Kałuzewski S; Połowniak-Pracka H; Szych J; Zaleska M
    Med Dosw Mikrobiol; 1985; 37(3-4):147-64. PubMed ID: 2421117
    [No Abstract]   [Full Text] [Related]  

  • 73. Crossed immuno-electrophoretic analysis of Yersinia enterocolitica serotype 0:3 antigens.
    Paerregaard A; Espersen F; Baek L; Høiby N
    APMIS; 1988 Apr; 96(4):306-14. PubMed ID: 3370155
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Use of the phenol fraction of Brucella for isolating a specific serum against Yersinia enterocolitica serovar O9].
    Sokolova EE; Iagovkin EA; Gurleva GG
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):49-52. PubMed ID: 3898661
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The cellular immune response against Yersinia enterocolitica in different inbred strains of mice: evidence for an important role of T lymphocytes.
    Autenrieth IB; Beer M; Hantschmann P; Preger S; Vogel U; Heymer B; Heesemann J
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):383-95. PubMed ID: 8347942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
    Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
    Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Immunoglobulin E level in acute Yersinia infection].
    Iushchuk ND; Valishin DA; Novikova TA; Eremina OF
    Klin Med (Mosk); 1991 Apr; 69(4):71-3. PubMed ID: 1865657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bacterial cytokine antagonists encoded by pathogenic yersiniae.
    Beuscher HU; Burdack S; Röllinghoff M
    Behring Inst Mitt; 1997 Feb; (98):240-8. PubMed ID: 9382746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A new branched-chain monosaccharide from the Yersinia enterocolitica serotype O:4.32 lipopolysaccharide].
    Gorshkova RP; Zubkov VA; Isakov VV; Ovodov IuS
    Bioorg Khim; 1987 Aug; 13(8):1146-7. PubMed ID: 2445358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immunostimulating effect of culture filtrates of Yersinia enterocolitica].
    Bundschuh G; Nattermann H
    Arch Exp Veterinarmed; 1990; 44(1):75-82. PubMed ID: 2344242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.